In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific ...

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...

Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

Genetic testing on embryos is more sophisticated and accessible than ever—and it’s now being sold as a way to let parents pick their future baby’s best traits.

Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.

A Northwestern Medicine study has revealed a previously unknown connection between two fundamental cellular processes, ...

Texas A&M AgriLife faculty, staff and graduate students earn Vice Chancellor’s Awards in Excellence honors at Texas A&M ...

According to officials with the Orleans Parish district attorney's office, a report from an expert submitted by Chris ...

Scientists at Mount Sinai have created an artificial intelligence system that can predict how likely rare genetic mutations are to actually cause disease. By combining machine learning with millions ...

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development ...